questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NICE's adoption of the EQ-5D-5L value set on the price of medicines with a quality of life benefit and no survival; and whether he plans to take steps to ensure that access to medicines which support workforce participation and productivity is not adversely affected.
answerText: The National Institute for Health and Care Excellence (NICE) is planning to adopt the EQ-5D-5L and has opened a consultation on the proposed changes to its guidance development manuals.The consultation opened on 15 April and includes the proposed changes ...
heading: Medical Treatments: Standards